Whitehawk Therapeutics (WHWK) Net Margin (2018 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Net Margin data on file, last reported at 1021.92% in Q1 2025.

• On a quarterly basis, Net Margin rose 138943.0% year-over-year to 1021.92% in Q1 2025; TTM through Dec 2025 was 416.0%, a 17032.0% decrease from a year earlier, with the FY2025 full-year figure at 227.73%, up 1740.0% from the prior year.
• Net Margin for Q1 2025 stood at 1021.92%, up from 213.87% in the prior quarter.
• Over the last five years, Net Margin for WHWK reached as high as 1021.92% in Q1 2025 and fell as low as 3701.45% in Q1 2021.
• Historically, Net Margin has averaged 442.0% across 5 years, with a median of 266.18% in 2022.
• Across the five-year window, Net Margin plunged 17149 bps in 2021 and jumped 310080 bps in 2022, its largest moves.
• Year by year, Net Margin stood at 114.21% in 2021, then tumbled by 133 bps to 266.18% in 2022, then advanced by 3 bps to 257.18% in 2023, then grew by 17 bps to 213.87% in 2024, then surged by 578 bps to 1021.92% in 2025.
• Per Business Quant data, the three most recent Net Margin figures were 1021.92% in Q1 2025, 213.87% in Q4 2024, and 177.44% in Q3 2024.